Tissue-engineered vascular grafts (TEVGs) that optimally mimic the ECM interactome hold immense potential to meet the growing demand for vascular surgeries, including hemodialysis access and ...

A new way to detect the onset of heart and kidney disease far earlier than previously possible has been discovered by ...

Artificial intelligence shows promise for improving care for peripheral artery disease through earlier detection, improved ...

Appointed Jim Mercadante as Chief Commercial Officer and Dr. Todd Rasmussen as Chief Surgical Officer - - First quarter sales of Symvess® were ...

Humacyte reported Q1 2026 financial results showing sales increased to $500,000 in Q1 2025, but the biotech company is ...

Distinguished vascular surgeon brings decades of clinical experience, innovation, and leadership to new role at cutting-edge biotech ...

Cognitive pressure disrupts muscle control and blood flow, highlighting its role in physical performance during low-intensity ...

Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial ...

Bill Colone, a medical executive who has built a career on commercializing doctors’ ideas, has launched a new venture. His new company Life Seal Vascular has built a device to solve an issue ...

Microfluidic architecture with vascular and tumor chambers recreates perfusion and desmoplastic stroma, enabling longitudinal visualization of PDAC cell–stromal dynamics under near-physiologic flow.

A fractured rib from one of the largest Tyrannosaurus rex specimens ever found still contains a network of structures that ...

Identification of mangostins as potent BK channel activators links natural xanthones to vascular smooth muscle relaxation, providing a mechanistic basis for their reported antihypertensive effects.